{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:47:06Z","timestamp":1767973626568,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"vor","delay-in-days":851,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden (Swedish Heart-Lung Foundation)","doi-asserted-by":"publisher","award":["20150273"],"award-info":[{"award-number":["20150273"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det (VR)","doi-asserted-by":"publisher","award":["521\u20132010-2929"],"award-info":[{"award-number":["521\u20132010-2929"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det (VR)","doi-asserted-by":"publisher","award":["2015\u201302811"],"award-info":[{"award-number":["2015\u201302811"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1074\/jbc.ra117.000292","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T14:41:25Z","timestamp":1521816085000},"page":"6791-6801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice"],"prefix":"10.1016","volume":"293","author":[{"given":"Polyxeni T.","family":"Mantani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pontus","family":"Dun\u00e9r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Ljungcrantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Sundius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fong","family":"To","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Bj\u00f6rkbacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunilla Nordin","family":"Fredrikson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA117.000292_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol"},{"key":"10.1074\/jbc.RA117.000292_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","article-title":"Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines","volume":"145","author":"Frosteg\u00e5rd","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1074\/jbc.RA117.000292_bib3","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1073\/pnas.92.9.3893","article-title":"T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein","volume":"92","author":"Stemme","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA117.000292_bib4","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1073\/pnas.0409015102","article-title":"T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses","volume":"102","author":"Buono","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA117.000292_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.ATV.0000059419.11002.6E","article-title":"Influence of interferon-\u03b3 on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse","volume":"23","author":"Buono","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.000292_bib6","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-\u03b3 potentiates atherosclerosis in ApoE knock-out mice","volume":"99","author":"Gupta","year":"1997","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000292_bib7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","article-title":"Exogenous interferon-\u03b3 enhances atherosclerosis in apolipoprotein E\u2212\/\u2212 mice","volume":"157","author":"Whitman","year":"2000","journal-title":"Am J. Pathol"},{"key":"10.1074\/jbc.RA117.000292_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1172\/JCI200420479","article-title":"IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis","volume":"114","author":"Binder","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000292_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1194\/jlr.M600361-JLR200","article-title":"Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events","volume":"48","author":"Tsimikas","year":"2007","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA117.000292_bib10","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.atherosclerosis.2006.12.014","article-title":"Autoantibody against the amino acid sequence 661\u2013680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events","volume":"194","author":"Fredrikson","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1074\/jbc.RA117.000292_bib11","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/eurheartj\/ehn336","article-title":"High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction","volume":"29","author":"Sj\u00f6gren","year":"2008","journal-title":"Eur. Heart J"},{"key":"10.1074\/jbc.RA117.000292_bib12","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)63471-2","article-title":"The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice","volume":"163","author":"Davenport","year":"2003","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.RA117.000292_bib13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/hq0302.104905","article-title":"Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor\u2212\/\u2212 mice","volume":"22","author":"King","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.000292_bib14","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1161\/01.CIR.103.21.2610","article-title":"T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia","volume":"103","author":"Huber","year":"2001","journal-title":"Circulation"},{"key":"10.1074\/jbc.RA117.000292_bib15","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.2353\/ajpath.2007.060857","article-title":"Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice","volume":"171","author":"King","year":"2007","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.RA117.000292_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.RA117.000292_bib17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/emmm.201201374","article-title":"Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype","volume":"4","author":"Cardilo-Reis","year":"2012","journal-title":"EMBO Mol. Med"},{"key":"10.1074\/jbc.RA117.000292_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCRESAHA.111.261784","article-title":"The IL-17A\/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment","volume":"110","author":"Butcher","year":"2012","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.RA117.000292_bib19","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","article-title":"Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice","volume":"183","author":"Erbel","year":"2009","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA117.000292_bib20","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","article-title":"Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1074\/jbc.RA117.000292_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","article-title":"Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"32","author":"Danzaki","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.000292_bib22","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1084\/jem.20090545","article-title":"Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis","volume":"206","author":"Taleb","year":"2009","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.RA117.000292_bib23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","article-title":"IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo","volume":"15","author":"Fort","year":"2001","journal-title":"Immunity"},{"key":"10.1074\/jbc.RA117.000292_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"key":"10.1074\/jbc.RA117.000292_bib25","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"key":"10.1074\/jbc.RA117.000292_bib26","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13-expressing cells in type 2 immunity","volume":"107","author":"Price","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA117.000292_bib27","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nature08901","article-title":"IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses","volume":"464","author":"Saenz","year":"2010","journal-title":"Nature"},{"key":"10.1074\/jbc.RA117.000292_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117255","article-title":"IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice","volume":"10","author":"Mantani","year":"2015","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA117.000292_bib29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1084\/jem.20051496","article-title":"Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract","volume":"203","author":"Owyang","year":"2006","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.RA117.000292_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1084\/jem.20061738","article-title":"IL-25 regulates Th17 function in autoimmune inflammation","volume":"204","author":"Kleinschek","year":"2007","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.RA117.000292_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00000441-200201000-00002","article-title":"Mouse models of atherosclerosis","volume":"323","author":"Daugherty","year":"2002","journal-title":"Am. J. Med. Sci"},{"key":"10.1074\/jbc.RA117.000292_bib32","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nm1459","article-title":"Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis","volume":"12","author":"Clarke","year":"2006","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA117.000292_bib33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/path.2667","article-title":"Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques","volume":"220","author":"de Boer","year":"2010","journal-title":"J. Pathol"},{"key":"10.1074\/jbc.RA117.000292_bib34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","article-title":"Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis","volume":"115","author":"Feil","year":"2014","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.RA117.000292_bib35","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"Shankman","year":"2015","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA117.000292_bib36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/ATVBAHA.114.304029","article-title":"Cholesterol loading reprograms the microRNA-143\/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype","volume":"35","author":"Vengrenyuk","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.000292_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.it.2010.09.001","article-title":"Innate immune cell populations function as initiators and effectors in Th2 cytokine responses","volume":"31","author":"Saenz","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1074\/jbc.RA117.000292_bib38","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.ATV.19.3.734","article-title":"The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice","volume":"19","author":"Lee","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.000292_bib39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1172\/JCI0215310","article-title":"Splenic immunity and atherosclerosis: a glimpse into a novel paradigm?","volume":"109","author":"Witztum","year":"2002","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000292_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI7272","article-title":"Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice","volume":"109","author":"Caligiuri","year":"2002","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA117.000292_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcmg.2014.10.009","article-title":"Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans","volume":"8","author":"Emami","year":"2015","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1074\/jbc.RA117.000292_bib42","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2796.2010.02311.x","article-title":"Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine","volume":"269","author":"Wigren","year":"2011","journal-title":"J. Intern. Med"},{"key":"10.1074\/jbc.RA117.000292_bib43","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/ATVBAHA.115.306048","article-title":"Expansion of CD25+ innate lymphoid cells reduces atherosclerosis","volume":"35","author":"Engelbertsen","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1074\/jbc.RA117.000292_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15781","article-title":"Type-2 innate lymphoid cells control the development of atherosclerosis in mice","volume":"8","author":"Newland","year":"2017","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA117.000292_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","article-title":"MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+ T cells potentiates type 2 immunity and promotes parasitic helminth expulsion","volume":"41","author":"Oliphant","year":"2014","journal-title":"Immunity"},{"key":"10.1074\/jbc.RA117.000292_bib46","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.20051615","article-title":"Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion","volume":"203","author":"Fallon","year":"2006","journal-title":"J. Exp. Med"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820410580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820410580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA117.000292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T11:01:20Z","timestamp":1641294080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820410580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":46,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0021925820410580"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra117.000292","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA117.000292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Biochemistry and Molecular Biology, Inc.","name":"copyright","label":"Copyright"}]}}